Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
David Scott MooreDirector | Corvus PharmaceuticalsCRVS | Open-market buy | 06/11 | 06/15 | 21,700 sh | $11.53 | $250,201 | No record |
Corvus PharmaceuticalsCRVS | Open-market buy | 05/18 | 05/20 | 6,932 sh2 trades | $12.04avg. | $83,453.32 | +0.6% | |
Orbimed AdvisorsDirector | Corvus PharmaceuticalsCRVS | Open-market sale | 25/06/27 | 25/07/01 | 1,176,332 sh | $4.16 | $4,893,541.12 | −14.1% |
Peter A. ThompsonDirector | Corvus PharmaceuticalsCRVS | Open-market sale | 25/06/27 | 25/07/01 | 1,176,332 sh | $4.16 | $4,893,541.12 | −14.1% |
OrbiMed Capital GP VDirector | Corvus PharmaceuticalsCRVS | Open-market sale | 25/06/27 | 25/07/01 | 1,176,332 sh | $4.16 | $4,893,541.12 | −14.1% |
Richard A. Md MillerPresident and CEO | Corvus PharmaceuticalsCRVS | Open-market buy | 24/05/06 | 24/05/07 | 577,634 sh | $1.73 | $999,306.82 | No record |
William Benton JonesSEE REMARKS | Corvus PharmaceuticalsCRVS | Open-market buy | 24/05/06 | 24/05/07 | 20,000 sh | $1.73 | $34,600 | +15.0% |
Linda GraisDirector | Corvus PharmaceuticalsCRVS | Open-market buy | 23/05/15 | 23/05/16 | 10,000 sh | $2.45 | $24,500 | No record |